Home About Us Pipeline News Investors Contacts Careers


News

Recent Press Releases Archives

Recent Press Releases

2013 News Releases

Dec. 17, 2013 - Puma Biotechnology to Hold Conference Call to Provide Update on PB272 Clinical Trials in Patients with HER2 Mutations Read

Dec. 4, 2013 - Puma Biotechnology Reports Positive Top Line Data from I-SPY 2 TRIAL
Neratinib Graduates from I-SPY 2 TRIAL Read

Nov. 12, 2013 - Puma Biotechnology Reports Third Quarter 2013 Financial Results Read

Oct. 4, 2013 - Puma Biotechnology Initiates Phase II Trial of PB272 (Neratinib) in HER2 Mutation-Positive Solid Tumor Patients Read

Sept. 4, 2013 - Puma Biotechnology to Present at Stifel Healthcare Conference Read

Aug. 6, 2013 - Puma Biotechnology Reports Second Quarter 2013 Financial Results Read

June 24, 2013 - Puma Biotechnology to Join Russell 3000 Index Read

June 7, 2013 - Puma Biotechnology Initiates Phase III Trial of PB272 (Neratinib) in HER2-Positive Metastatic Breast Cancer Patients Read

June 5, 2013 - Puma Biotechnology to Present at Goldman Sachs Healthcare Conference Read

May 29, 2013 - Puma Biotechnology to Present at Jefferies Global Healthcare Conference Read

May 17, 2013 - Puma Biotechnology Comment on Trading Activity Read

May 14, 2013 - Puma Biotechnology to Present at UBS Global Healthcare Conference Read

May 9, 2013 - Puma Biotechnology Reports First Quarter 2013 Financial Results Read

May 8, 2013 - Puma Biotechnology to Present at Bank of America Merrill Lynch 2013 Health Care Conference Read

April 1, 2013 - Puma Biotechnology Reports Fourth Quarter and Full Year 2012 Financial Results Read

Feb. 26, 2013 - Puma Biotechnology to Present at Cowen Health Care Conference Read

Feb. 20, 2013 - Puma Biotechnology Announces Agreement with FDA on Special Protocol Assessment for Phase III Trial of PB272 (Neratinib) in HER2-Positive Metastatic Breast Cancer Patients Read

Feb. 6, 2013 - Puma Biotechnology to Present at Leerink Swann Global Healthcare Conference Read


Corporate Fact Sheet

Puma Biotechnology, Inc.

10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax